Search

Novel method of protein purification for structural research. Example of ultra high resolution structure of SPI-2 inhibitor by X-ray and NMR spectroscopy.
Authors
Lenarcic Zivkovic, M., Dvornyk, A., Kludkiewicz, B., Kopera, E., Zagorski-Ostoja, W., Grzelak, K., Zhukov, I., Bal, W.
Assembly
SPI-2 inhibitor
Entity
1. SPI-2 inhibitor (polymer, Thiol state: all disulfide bound), 40 monomers, 4314.717 Da Detail

EAAVCTTEWD PVCGKDGKTY SNLCWLNEAG VGLDHEGECL


Formula weight
4314.717 Da
Entity Connection
disulfide 2 Detail

IDTypeValue orderAtom ID 1Atom ID 2
1disulfidesing1:CYS5:SG1:CYS24:SG
2disulfidesing1:CYS13:SG1:CYS39:SG

Source organism
Galleria mellonella
Exptl. method
solution NMR
Refine. method
molecular dynamics
Data set
assigned_chemical_shifts
Chem. Shift Complete
Sequence coverage: 100.0 %, Completeness: 83.2 %, Completeness (bb): 76.5 % Detail

Polymer type: polypeptide(L)

Total1H13C15N
All83.2 % (351 of 422)95.8 % (205 of 214)63.0 % (104 of 165)97.7 % (42 of 43)
Backbone76.5 % (182 of 238)97.6 % (82 of 84)53.9 % (62 of 115)97.4 % (38 of 39)
Sidechain91.3 % (200 of 219)94.6 % (123 of 130)85.9 % (73 of 85)100.0 % (4 of 4)
Aromatic83.3 % (30 of 36)88.9 % (16 of 18)75.0 % (12 of 16)100.0 % (2 of 2)
Methyl90.0 % (36 of 40)90.0 % (18 of 20)90.0 % (18 of 20)

1. GmSPI 2

EAAVCTTEWD PVCGKDGKTY SNLCWLNEAG VGLDHEGECL

Sample

Solvent system 90% H2O/10% D2O, Pressure 1 atm, Temperature 298 K, pH 4.5


#NameIsotope labelingTypeConcentration
1GmSPI 2natural abundance0.5 mM

Protein Blocks Logo
Calculated from 17 models in PDB: 2M5X, Strand ID: A Detail


Release date
2014-03-09
Citation
Ultrahigh resolution protein structure enabled by a non-enzymatic tag removal method. X-ray and NMR study of SPI-2 inhibitor
Kopera, E., Krzywda, S., Lenarcic Zivkovic, M., Dvornyk, A., Kludkiewicz, B., Grzelak, K., Zhukov, I., Zagorski-Ostoja, W., Jaskolski, M., Bal, W.
Not known
Related entities 1. SPI-2 inhibitor, : 1 : 1 : 212 entities Detail
Experiments performed 5 experiments Detail
NMR combined restraints 4 contents Detail
Keywords Kazal family, serine protease inhibitor, SPI-2